264
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Is shorter transient middle cerebral artery occlusion (t-MCAO) duration better in stroke experiments on diabetic female Sprague Dawely rats?

, , , &
Pages 1390-1396 | Received 12 Sep 2015, Accepted 07 May 2016, Published online: 19 Aug 2016

References

  • Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, Fineberg SE, Tierney WR. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67–71.
  • Kaarisalo MM, Raiha I, Sivenius J, Immonen-Raiha P, Lehtonen A, Sarti C, Mähönen M, Torppa J, Tuomilehto J, Salomaa V. Diabetes worsens the outcome of acute ischemic stroke. Diabetes Research & Clinical Practice 2005;69:293–298.
  • Janghorbani M, Hu FB, Willett WC, Li TY, Manson JE, Logroscino G, Rexrode KM. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses’ Health Study. Diabetes Care 2007;30:1730–1735.
  • Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM. High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 2006;29:798–804.
  • Secrest AM, Prince CT, Costacou T, Miller RG, Orchard TJ. Predictors of and survival after incident stroke in type 1 diabetes. Diabetes & Vascular Disease Research 2013;1:3–10.
  • Jauch EC, Saver JL, Adams HP Jr., Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr., Qureshi AI, Rosenfield K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013;44:870–947.
  • Nagasawa H, Kogure K. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989;20:1037–1043.
  • Lan X, Qu H, Yao W, Zhang C. Granulocyte-colony stimulating factor inhibits neuronal apoptosis in rat model of diabetic cerebral ischemia. Tohoku Journal of Experimental Medicine 2008;216:117–126.
  • Fan X, Qiu J, Yu Z, Dai H, Singhal AB, Lo EH, Wang X. A rat model of studying tissue-type plasminogen activator thrombolysis in ischemic stroke with diabetes. Stroke 2012;43:567–570.
  • Ning R, Chopp M, Yan T, Zacharek A, Zhang C, Roberts C, Cui X, Lu M, Chen J. Tissue plasminogen activator treatment of stroke in type-1 diabetes rats. Neuroscience 2012;222:326–332.
  • Elgebaly MM, Ogbi S, Li W, Mezzetti EM, Prakash R, Johnson MH, Bruno A, Fagan SC, Ergul A. Neurovascular injury in acute hyperglycemia and diabetes: a comparative analysis in experimental stroke. Translational Stroke Research 2011;2:391–398.
  • Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, Cui Y, Zacharek A, Roberts C, Liu X, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 2011;42:3551–3558.
  • Kusaka I, Kusaka G, Zhou C, Ishikawa M, Nanda A, Granger DN, Zhang JH, Tang J. Role of AT1 receptors and NAD(P)H oxidase in diabetes-aggravated ischemic brain injury. American Journal of Physiology Heart & Circulatory Physiology 2004;286:2442–2451.
  • Ye X, Yan T, Chopp M, Zacharek A, Ning R, Venkat P, Roberts C, Chen J. BMSC and Niaspan treatment of stroke enhances white matter remodeling and synaptic protein expression in diabetic rats. International Journal of Molecular Sciences 2013;14:22221–22232.
  • Ye X, Chopp M, Liu X, Zacharek A, Cui X, Yan T, Roberts C, Chen J. Niaspan reduces high-mobility group box 1/receptor for advanced glycation end products after stroke in type-1 diabetic rats. Neuroscience 2011;190:339–345.
  • Ye X, Chopp M, Cui X, Zacharek A, Cui Y, Yan T, Shehadah A, Roberts C, Liu X, Lu M, et al. Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats. Experimental Neurology 2011;232:299–308.
  • Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke 2009;40:604–609.
  • Toung TK, Hurn PD, Traystman RJ, Sieber FE. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 2000;31:2701–2706.
  • Niessen F, Hilger T, Hoehn M, Hossmann KA. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 2003;34:2019–2024.
  • Wang CX, Yang T, Shuaib A. An improved version of embolic model of brain ischemic injury in the rat. Journal of Neuroscience Methods 2001;109:147–151.
  • Kong Q, Hafeez A, Yu W, Ren C, Geng X, Xiao Y, Liu S, Zhang Y, Mao R, Zhou J, Ding Y, Ji X Acute recanalization of carotid stenosis is not proper: an experimental ischaemic stroke study. Neurological Research 2015;37:397–402.
  • Park SI, Park SK, Jang KS, Han YM, Kim CH, Oh SJ. Preischemic neuroprotective effect of minocycline and sodium ozagrel on transient cerebral ischemic rat model. Brain Research 2015;1599:85–92.
  • Akbarzadeh A, Norouzian D, Mehrabi MR, Jamshidi Sh, Farhangi A, Verdi AA, Mofidian SM, Rad BL. Induction of diabetes by Streptozotocin in rats. Indian Journal of Clinical Biochemistry 2007;22:60–64.
  • Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian Journal of Medical Research 2007;125:451–472.
  • Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema. I.: a new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Japanese Journal of Stroke 1986;8:1–8.
  • Zea Longa EL, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84–91.
  • Zhang PB, Liu Y. Effects of ketamine-midazolam anesthesia on focal cerebral ischemic injury in rats. Journal of First Military Medicine University 2004;12:1337–1341.
  • Renic M, Klaus JA, Omura T, Kawashima N, Onishi M, Miyata N, Koehler RC, Harder DR, Roman RJ. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. Journal of Cerebral Blood Flow & Metabolism 2009;29:629–639.
  • Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5- triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986;17:1304–1308.
  • Dittmar MS, Vatankhah B, Fehm NP, Schuierer G, Bogdahn U, Horn M, Schlachetzki F. Fisher-344 rats are unsuitable for MCAO filament model due to their cerebrovascular anatomy. Journal of Neuroscience Methods 2006;156:50–54.
  • Carmichael ST. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005;3:396–409.
  • Toung TK, Hurn PD, Traystman RJ, Sieber FE. Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus. Stroke 2000;31:2701–2706.
  • Wang Q, Peng Y, Chen S, Gou X, Hu B, Du J, Lu Y, Xiong L Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009;40:2157–2164.
  • Dunn KM, Renic M, Flasch AK, Harder DR, Falck J, Roman RJ. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. American Journal of Physiology Heart & Circulatory Physiology 2008;295:2455–2465.
  • Tsuruta R, Fujita M, Ono T, Koda Y, Koga Y, Yamamoto T, Nanba M, Shitara M, Kasaoka S, Maruyama I, et al. Hyperglycemia enhances excessive superoxide anion radical generation, oxidative stress, early inflammation, and endothelial injury in forebrain ischemia/reperfusion rats. Brain Research 2010;1309:155–163.
  • Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. Journal of Clinical Investigation 2001;108:949–955.
  • Melton JE, Nattie EE. Intracranial volume adjustments and cerebrospinal fluid pressure in the osmotically swollen rat brain. American Journal of Physiology 1984;246:533–541.
  • Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial: TOAST.Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35–41.
  • Brott T, Marler JR, Olinger CP, Adams HP Jr., Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke 1989;20:871–875.
  • Nopoulos P, Flaum M, O’Leary D, Andreasen NC. Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging. Psychiatry Research 2000;98:1–13.
  • Oppenheim C, Samson Y, Manaï R, Lalam T, Vandamme X, Crozier S, Srour A, Cornu P, Dormont D, Rancurel G, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000;31:2175–2181.
  • Mori K, Aoki A, Yamamoto T, Horinaka N, Maeda M. Aggressive decompressive surgery in patients with massive hemispheric embolic cerebral infarction associated with severe brain swelling. Acta Neurochirurgica 2001;143:483–491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.